Pharmakon Distributors Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 09-12-2024
- Paid Up Capital ₹ 0.10 M
as on 09-12-2024
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 0.24 M
as on 09-12-2024
- Revenue %
(FY 2020)
- Ebitda
- Net Worth -26.15%
(FY 2020)
- Total Assets -35.68%
(FY 2020)
About Pharmakon Distributors
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹0.24 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vinty Khemani, Vineet Khemani, and Rajkumari Khemani serve as directors at the Company.
- CIN/LLPIN
U51909WB2013PTC193480
- Company No.
193480
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 May 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pharmakon Distributors?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinty Khemani  | Director | 29-Sep-2015 | Current |
| Vineet Khemani | Director | 20-May-2013 | Current |
| Rajkumari Khemani | Director | 21-May-2013 | Current |
Financial Performance of Pharmakon Distributors.
Pharmakon Distributors Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 26.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Pharmakon Distributors?
In 2017, Pharmakon Distributors had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rememax Pharmaceuticals Private LimitedActive 11 years 7 monthsVinty Khemani, Vineet Khemani and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 25 Jun 2021 | ₹0.24 M | Satisfied |
How Many Employees Work at Pharmakon Distributors?
Unlock and access historical data on people associated with Pharmakon Distributors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmakon Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmakon Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
